143 related articles for article (PubMed ID: 10347750)
21. Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions.
Miquerol L; Cluzeaud F; Porteu A; Alexandre Y; Vandewalle A; Kahn A
Gene Expr; 1996; 5(6):315-30. PubMed ID: 8836739
[TBL] [Abstract][Full Text] [Related]
22. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
[TBL] [Abstract][Full Text] [Related]
23. Muscle creatine kinase/SV40 hybrid promoter for muscle-targeted long-term transgene expression.
Takeshita F; Takase K; Tozuka M; Saha S; Okuda K; Ishii N; Sasaki S
Int J Mol Med; 2007 Feb; 19(2):309-15. PubMed ID: 17203206
[TBL] [Abstract][Full Text] [Related]
24. Effect of promoter, promoter mutation and enhancer on transgene expression mediated by episomal vectors in transfected HEK293, Chang liver and primary cells.
Xu ZJ; Jia YL; Wang M; Yi DD; Zhang WL; Wang XY; Zhang JH
Bioengineered; 2019 Dec; 10(1):548-560. PubMed ID: 31668126
[TBL] [Abstract][Full Text] [Related]
25. Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells.
Mao Y; Yan R; Li A; Zhang Y; Li J; Du H; Chen B; Wei W; Zhang Y; Sumners C; Zheng H; Li H
Int J Med Sci; 2015; 12(5):407-15. PubMed ID: 26005375
[TBL] [Abstract][Full Text] [Related]
26. Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers.
Yan Z; Sun X; Feng Z; Li G; Fisher JT; Stewart ZA; Engelhardt JF
Hum Gene Ther; 2015 Jun; 26(6):334-46. PubMed ID: 25763813
[TBL] [Abstract][Full Text] [Related]
27. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
Chen P; Tian J; Kovesdi I; Bruder JT
J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
[TBL] [Abstract][Full Text] [Related]
28. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
Kachi S; Esumi N; Zack DJ; Campochiaro PA
Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
[TBL] [Abstract][Full Text] [Related]
29. Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1 alpha promoter system.
Chan KK; Wu SM; Nissom PM; Oh SK; Choo AB
Stem Cells Dev; 2008 Aug; 17(4):825-36. PubMed ID: 18788934
[TBL] [Abstract][Full Text] [Related]
30. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
[TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis of luciferase activity of viral and hybrid promoters in bovine preimplantation embryos.
Nakamura A; Okumura J; Muramatsu T
Mol Reprod Dev; 1998 Apr; 49(4):368-73. PubMed ID: 9508087
[TBL] [Abstract][Full Text] [Related]
32. The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors.
Alexopoulou AN; Couchman JR; Whiteford JR
BMC Cell Biol; 2008 Jan; 9():2. PubMed ID: 18190688
[TBL] [Abstract][Full Text] [Related]
33. Diverse plasmid DNA vectors by directed molecular evolution of cytomegalovirus promoters.
Wright A; Semyonov A; Dawes G; Crameri A; Lyons R; Stemmer WP; Apt D; Punnonen J
Hum Gene Ther; 2005 Jul; 16(7):881-92. PubMed ID: 16000069
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of the relative luciferase activity in secondary CEF by different heterogenous strong promoters, MDV gB promoter and the composed promoters].
Qiu YF; Ge FF; Xu XQ; Chen PY
Wei Sheng Wu Xue Bao; 2006 Apr; 46(2):314-7. PubMed ID: 16736599
[TBL] [Abstract][Full Text] [Related]
35. An internal polyadenylation signal substantially increases expression levels of lentivirus-delivered transgenes but has the potential to reduce viral titer in a promoter-dependent manner.
Hager S; Frame FM; Collins AT; Burns JE; Maitland NJ
Hum Gene Ther; 2008 Aug; 19(8):840-50. PubMed ID: 18627247
[TBL] [Abstract][Full Text] [Related]
36. Activator protein 1-mediated transcriptional regulation strategy sustains long-term expression of a xenogeneic gene product in vivo: an implication for gene therapy targeting congenital protein deficiencies.
Sasaki S; Smith JM; Takase K; Okuda K; Ishii N; Takeshita F
Int J Mol Med; 2006 Aug; 18(2):289-97. PubMed ID: 16820937
[TBL] [Abstract][Full Text] [Related]
37. Constant and steady transgene expression of interferon-γ by optimization of plasmid construct for safe and effective interferon-γ gene therapy.
Ando M; Takahashi Y; Nishikawa M; Watanabe Y; Takakura Y
J Gene Med; 2012 Apr; 14(4):288-95. PubMed ID: 22359360
[TBL] [Abstract][Full Text] [Related]
38. Characterization of constitutive promoters for piggyBac transposon-mediated stable transgene expression in mesenchymal stem cells (MSCs).
Wen S; Zhang H; Li Y; Wang N; Zhang W; Yang K; Wu N; Chen X; Deng F; Liao Z; Zhang J; Zhang Q; Yan Z; Liu W; Zhang Z; Ye J; Deng Y; Zhou G; Luu HH; Haydon RC; Shi LL; He TC; Wei G
PLoS One; 2014; 9(4):e94397. PubMed ID: 24714676
[TBL] [Abstract][Full Text] [Related]
39. Optimization of plasmid vectors for high-level expression in lung epithelial cells.
Yew NS; Wysokenski DM; Wang KX; Ziegler RJ; Marshall J; McNeilly D; Cherry M; Osburn W; Cheng SH
Hum Gene Ther; 1997 Mar; 8(5):575-84. PubMed ID: 9095409
[TBL] [Abstract][Full Text] [Related]
40. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
